APO Research
Talk to an analyst

APO RESEARCH · REPORT

EMOCAP

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global EMOCAP Market Analysis and Forecast 2026-2032

4 June 2026209 pages

Choose your research edition.

Industry ResearchEMOCAP Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal EMOCAP Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal EMOCAP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EMOCAP Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal EMOCAP Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global EMOCAP market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for EMOCAP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for EMOCAP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for EMOCAP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for EMOCAP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of EMOCAP include StretchSense, Noitom, Vicon, Cyber Glove Systems, Rokoko, MANUS, AiQ Synertial, Virtual Motion Labs and PhaseSpace, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for EMOCAP, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of EMOCAP, also provides the revenue of main regions and countries. Of the upcoming market potential for EMOCAP, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the EMOCAP revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global EMOCAP market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for EMOCAP revenue, projected growth trends, production technology, application and end-user industry.

EMOCAP Segment by Company

StretchSense

Noitom

Vicon

Cyber Glove Systems

Rokoko

MANUS

AiQ Synertial

Virtual Motion Labs

PhaseSpace

VRTRIX

HaptX

Virdyn

Qualisys AB

Xsens Technologyes

Optitrack

Codamotion

PTI Phoenix Technologies

Noraxon USA

NTT Data

EMOCAP Segment by Type

Whole Boby

Part Boby

EMOCAP Segment by Application

Scientific Research

Entertainment

Medical

Other

EMOCAP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EMOCAP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EMOCAP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EMOCAP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of EMOCAP in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of EMOCAP company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EMOCAP revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global EMOCAP Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Whole Boby Major Player Table 3. Part Boby Major Player Table 4. Global EMOCAP Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Scientific Research Major Player Table 6. Entertainment Major Player Table 7. Medical Major Player Table 8. Other Major Player Table 9. EMOCAP Industry Trends Table 10. EMOCAP Industry Drivers Table 11. EMOCAP Industry Opportunities and Challenges Table 12. EMOCAP Industry Restraints Table 13. Global EMOCAP Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global EMOCAP Market Size by Region (2021-2026) & (US$ Million) Table 15. Global EMOCAP Market Share by Region (2021-2026) Table 16. Global EMOCAP Market Size by Region (2027-2032) & (US$ Million) Table 17. Global EMOCAP Market Share by Region (2027-2032) Table 18. Global EMOCAP Revenue by Players (US$ Million) & (2021-2026) Table 19. Global EMOCAP Revenue Market Share by Players (2021-2026) Table 20. Global EMOCAP Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global EMOCAP Key Players Headquarters & Area Served Table 22. Global EMOCAP Players, Product Type & Application Table 23. Global EMOCAP Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global EMOCAP by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global EMOCAP Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global EMOCAP Revenue by Type (2021-2026) & (US$ Million) Table 28. Global EMOCAP Revenue by Type (2027-2032) & (US$ Million) Table 29. Global EMOCAP Revenue Market Share by Type (2021-2026) Table 30. Global EMOCAP Revenue Market Share by Type (2027-2032) Table 31. Global EMOCAP Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global EMOCAP Revenue by Application (2021-2026) & (US$ Million) Table 33. Global EMOCAP Revenue by Application (2027-2032) & (US$ Million) Table 34. Global EMOCAP Revenue Market Share by Application (2021-2026) Table 35. Global EMOCAP Revenue Market Share by Application (2027-2032) Table 36. StretchSense Company Information Table 37. StretchSense Business Overview Table 38. StretchSense EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. StretchSense EMOCAP Product Portfolio Table 40. StretchSense Recent Development Table 41. Noitom Company Information Table 42. Noitom Business Overview Table 43. Noitom EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Noitom EMOCAP Product Portfolio Table 45. Noitom Recent Development Table 46. Vicon Company Information Table 47. Vicon Business Overview Table 48. Vicon EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Vicon EMOCAP Product Portfolio Table 50. Vicon Recent Development Table 51. Cyber Glove Systems Company Information Table 52. Cyber Glove Systems Business Overview Table 53. Cyber Glove Systems EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Cyber Glove Systems EMOCAP Product Portfolio Table 55. Cyber Glove Systems Recent Development Table 56. Rokoko Company Information Table 57. Rokoko Business Overview Table 58. Rokoko EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Rokoko EMOCAP Product Portfolio Table 60. Rokoko Recent Development Table 61. MANUS Company Information Table 62. MANUS Business Overview Table 63. MANUS EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. MANUS EMOCAP Product Portfolio Table 65. MANUS Recent Development Table 66. AiQ Synertial Company Information Table 67. AiQ Synertial Business Overview Table 68. AiQ Synertial EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AiQ Synertial EMOCAP Product Portfolio Table 70. AiQ Synertial Recent Development Table 71. Virtual Motion Labs Company Information Table 72. Virtual Motion Labs Business Overview Table 73. Virtual Motion Labs EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Virtual Motion Labs EMOCAP Product Portfolio Table 75. Virtual Motion Labs Recent Development Table 76. PhaseSpace Company Information Table 77. PhaseSpace Business Overview Table 78. PhaseSpace EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. PhaseSpace EMOCAP Product Portfolio Table 80. PhaseSpace Recent Development Table 81. VRTRIX Company Information Table 82. VRTRIX Business Overview Table 83. VRTRIX EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. VRTRIX EMOCAP Product Portfolio Table 85. VRTRIX Recent Development Table 86. HaptX Company Information Table 87. HaptX Business Overview Table 88. HaptX EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. HaptX EMOCAP Product Portfolio Table 90. HaptX Recent Development Table 91. Virdyn Company Information Table 92. Virdyn Business Overview Table 93. Virdyn EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Virdyn EMOCAP Product Portfolio Table 95. Virdyn Recent Development Table 96. Qualisys AB Company Information Table 97. Qualisys AB Business Overview Table 98. Qualisys AB EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Qualisys AB EMOCAP Product Portfolio Table 100. Qualisys AB Recent Development Table 101. Xsens Technologyes Company Information Table 102. Xsens Technologyes Business Overview Table 103. Xsens Technologyes EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Xsens Technologyes EMOCAP Product Portfolio Table 105. Xsens Technologyes Recent Development Table 106. Optitrack Company Information Table 107. Optitrack Business Overview Table 108. Optitrack EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Optitrack EMOCAP Product Portfolio Table 110. Optitrack Recent Development Table 111. Codamotion Company Information Table 112. Codamotion Business Overview Table 113. Codamotion EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Codamotion EMOCAP Product Portfolio Table 115. Codamotion Recent Development Table 116. PTI Phoenix Technologies Company Information Table 117. PTI Phoenix Technologies Business Overview Table 118. PTI Phoenix Technologies EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. PTI Phoenix Technologies EMOCAP Product Portfolio Table 120. PTI Phoenix Technologies Recent Development Table 121. Noraxon USA Company Information Table 122. Noraxon USA Business Overview Table 123. Noraxon USA EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Noraxon USA EMOCAP Product Portfolio Table 125. Noraxon USA Recent Development Table 126. NTT Data Company Information Table 127. NTT Data Business Overview Table 128. NTT Data EMOCAP Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. NTT Data EMOCAP Product Portfolio Table 130. NTT Data Recent Development Table 131. North America EMOCAP Revenue by Type (2021-2026) & (US$ Million) Table 132. North America EMOCAP Revenue by Type (2027-2032) & (US$ Million) Table 133. North America EMOCAP Revenue by Application (2021-2026) & (US$ Million) Table 134. North America EMOCAP Revenue by Application (2027-2032) & (US$ Million) Table 135. North America EMOCAP Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America EMOCAP Revenue by Country (2021-2026) & (US$ Million) Table 137. North America EMOCAP Revenue by Country (US$ Million) & (2027-2032) Table 138. Europe EMOCAP Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe EMOCAP Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe EMOCAP Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe EMOCAP Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe EMOCAP Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe EMOCAP Revenue by Country (2021-2026) & (US$ Million) Table 144. Europe EMOCAP Revenue by Country (US$ Million) & (2027-2032) Table 145. China EMOCAP Revenue by Type (2021-2026) & (US$ Million) Table 146. China EMOCAP Revenue by Type (2027-2032) & (US$ Million) Table 147. China EMOCAP Revenue by Application (2021-2026) & (US$ Million) Table 148. China EMOCAP Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia EMOCAP Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia EMOCAP Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia EMOCAP Revenue by Application (2021-2026) & (US$ Million) Table 152. Asia EMOCAP Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia EMOCAP Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia EMOCAP Revenue by Region (US$ Million) & (2021-2026) Table 155. Asia EMOCAP Revenue by Region (US$ Million) & (2027-2032) Table 156. SAMEA EMOCAP Revenue by Type (2021-2026) & (US$ Million) Table 157. SAMEA EMOCAP Revenue by Type (2027-2032) & (US$ Million) Table 158. SAMEA EMOCAP Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA EMOCAP Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA EMOCAP Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. SAMEA EMOCAP Revenue by Country (2021-2026) & (US$ Million) Table 162. SAMEA EMOCAP Revenue by Country (US$ Million) & (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. EMOCAP Image Figure 2. Global EMOCAP Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EMOCAP Market Size Share 2021 VS 2025 VS 2032 Figure 4. Whole Boby Image Figure 5. Part Boby Image Figure 6. Global EMOCAP Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global EMOCAP Market Size Share 2021 VS 2025 VS 2032 Figure 8. Scientific Research Image Figure 9. Entertainment Image Figure 10. Medical Image Figure 11. Other Image Figure 12. Global EMOCAP Market Size (US$ Million) & (2021-2032) Figure 13. Global EMOCAP Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global EMOCAP Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global EMOCAP Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global EMOCAP Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global EMOCAP Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global EMOCAP Revenue Market Share by Type (2021-2032) Figure 20. Global EMOCAP Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global EMOCAP Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global EMOCAP Revenue Market Share by Application (2021-2032) Figure 23. North America EMOCAP Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America EMOCAP Revenue Share by Type (2021-2032) Figure 25. North America EMOCAP Revenue Share by Application (2021-2032) Figure 26. North America EMOCAP Revenue Share by Country (2021-2032) Figure 27. United States EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe EMOCAP Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe EMOCAP Revenue Share by Type (2021-2032) Figure 32. Europe EMOCAP Revenue Share by Application (2021-2032) Figure 33. Europe EMOCAP Revenue Share by Country (2021-2032) Figure 34. Germany EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China EMOCAP Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China EMOCAP Revenue Share by Type (2021-2032) Figure 44. China EMOCAP Revenue Share by Application (2021-2032) Figure 45. Asia EMOCAP Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia EMOCAP Revenue Share by Type (2021-2032) Figure 47. Asia EMOCAP Revenue Share by Application (2021-2032) Figure 48. Asia EMOCAP Revenue Share by Region (2021-2032) Figure 49. Japan EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA EMOCAP Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA EMOCAP Revenue Share by Type (2021-2032) Figure 57. SAMEA EMOCAP Revenue Share by Application (2021-2032) Figure 58. SAMEA EMOCAP Revenue Share by Country (2021-2032) Figure 59. Brazil EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt EMOCAP Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Boby
  • Part Boby
Applications
  • Scientific Research
  • Entertainment
  • Medical
  • Other
Companies covered
  • StretchSense
  • Noitom
  • Vicon
  • Cyber Glove Systems
  • Rokoko
  • MANUS
  • AiQ Synertial
  • Virtual Motion Labs
  • PhaseSpace
  • VRTRIX
  • HaptX
  • Virdyn
  • Qualisys AB
  • Xsens Technologyes
  • Optitrack
  • Codamotion
  • PTI Phoenix Technologies
  • Noraxon USA
  • NTT Data

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 EMOCAP Market by Type
  3. 1.2.1 Global EMOCAP Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Whole Boby
  5. 1.2.3 Part Boby
  6. 1.3 EMOCAP Market by Application
  7. 1.3.1 Global EMOCAP Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Scientific Research
  9. 1.3.3 Entertainment
  10. 1.3.4 Medical
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 EMOCAP Market Dynamics
  1. 2.1 EMOCAP Industry Trends
  2. 2.2 EMOCAP Industry Drivers
  3. 2.3 EMOCAP Industry Opportunities and Challenges
  4. 2.4 EMOCAP Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global EMOCAP Market Perspective (2021-2032)
  2. 3.2 Global EMOCAP Growth Trends by Region
  3. 3.2.1 Global EMOCAP Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global EMOCAP Market Size by Region (2021-2026)
  5. 3.2.3 Global EMOCAP Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global EMOCAP Revenue by Players
  2. 4.1.1 Global EMOCAP Revenue by Players (2021-2026)
  3. 4.1.2 Global EMOCAP Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global EMOCAP Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global EMOCAP Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global EMOCAP Key Players Headquarters & Area Served
  7. 4.4 Global EMOCAP Players, Product Type & Application
  8. 4.5 Global EMOCAP Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global EMOCAP Market CR5 and HHI
  11. 4.6.3 2025 EMOCAP Tier 1, Tier 2, and Tier 3
5 EMOCAP Market Size by Type
  1. 5.1 Global EMOCAP Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global EMOCAP Revenue by Type (2021-2032)
  3. 5.3 Global EMOCAP Revenue Market Share by Type (2021-2032)
6 EMOCAP Market Size by Application
  1. 6.1 Global EMOCAP Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global EMOCAP Revenue by Application (2021-2032)
  3. 6.3 Global EMOCAP Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 StretchSense
  2. 7.1.1 StretchSense Company Information
  3. 7.1.2 StretchSense Business Overview
  4. 7.1.3 StretchSense EMOCAP Revenue and Gross Margin (2021-2026)
  5. 7.1.4 StretchSense EMOCAP Product Portfolio
  6. 7.1.5 StretchSense Recent Developments
  7. 7.2 Noitom
  8. 7.2.1 Noitom Company Information
  9. 7.2.2 Noitom Business Overview
  10. 7.2.3 Noitom EMOCAP Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Noitom EMOCAP Product Portfolio
  12. 7.2.5 Noitom Recent Developments
  13. 7.3 Vicon
  14. 7.3.1 Vicon Company Information
  15. 7.3.2 Vicon Business Overview
  16. 7.3.3 Vicon EMOCAP Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Vicon EMOCAP Product Portfolio
  18. 7.3.5 Vicon Recent Developments
  19. 7.4 Cyber Glove Systems
  20. 7.4.1 Cyber Glove Systems Company Information
  21. 7.4.2 Cyber Glove Systems Business Overview
  22. 7.4.3 Cyber Glove Systems EMOCAP Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Cyber Glove Systems EMOCAP Product Portfolio
  24. 7.4.5 Cyber Glove Systems Recent Developments
  25. 7.5 Rokoko
  26. 7.5.1 Rokoko Company Information
  27. 7.5.2 Rokoko Business Overview
  28. 7.5.3 Rokoko EMOCAP Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Rokoko EMOCAP Product Portfolio
  30. 7.5.5 Rokoko Recent Developments
  31. 7.6 MANUS
  32. 7.6.1 MANUS Company Information
  33. 7.6.2 MANUS Business Overview
  34. 7.6.3 MANUS EMOCAP Revenue and Gross Margin (2021-2026)
  35. 7.6.4 MANUS EMOCAP Product Portfolio
  36. 7.6.5 MANUS Recent Developments
  37. 7.7 AiQ Synertial
  38. 7.7.1 AiQ Synertial Company Information
  39. 7.7.2 AiQ Synertial Business Overview
  40. 7.7.3 AiQ Synertial EMOCAP Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AiQ Synertial EMOCAP Product Portfolio
  42. 7.7.5 AiQ Synertial Recent Developments
  43. 7.8 Virtual Motion Labs
  44. 7.8.1 Virtual Motion Labs Company Information
  45. 7.8.2 Virtual Motion Labs Business Overview
  46. 7.8.3 Virtual Motion Labs EMOCAP Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Virtual Motion Labs EMOCAP Product Portfolio
  48. 7.8.5 Virtual Motion Labs Recent Developments
  49. 7.9 PhaseSpace
  50. 7.9.1 PhaseSpace Company Information
  51. 7.9.2 PhaseSpace Business Overview
  52. 7.9.3 PhaseSpace EMOCAP Revenue and Gross Margin (2021-2026)
  53. 7.9.4 PhaseSpace EMOCAP Product Portfolio
  54. 7.9.5 PhaseSpace Recent Developments
  55. 7.10 VRTRIX
  56. 7.10.1 VRTRIX Company Information
  57. 7.10.2 VRTRIX Business Overview
  58. 7.10.3 VRTRIX EMOCAP Revenue and Gross Margin (2021-2026)
  59. 7.10.4 VRTRIX EMOCAP Product Portfolio
  60. 7.10.5 VRTRIX Recent Developments
  61. 7.11 HaptX
  62. 7.11.1 HaptX Company Information
  63. 7.11.2 HaptX Business Overview
  64. 7.11.3 HaptX EMOCAP Revenue and Gross Margin (2021-2026)
  65. 7.11.4 HaptX EMOCAP Product Portfolio
  66. 7.11.5 HaptX Recent Developments
  67. 7.12 Virdyn
  68. 7.12.1 Virdyn Company Information
  69. 7.12.2 Virdyn Business Overview
  70. 7.12.3 Virdyn EMOCAP Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Virdyn EMOCAP Product Portfolio
  72. 7.12.5 Virdyn Recent Developments
  73. 7.13 Qualisys AB
  74. 7.13.1 Qualisys AB Company Information
  75. 7.13.2 Qualisys AB Business Overview
  76. 7.13.3 Qualisys AB EMOCAP Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Qualisys AB EMOCAP Product Portfolio
  78. 7.13.5 Qualisys AB Recent Developments
  79. 7.14 Xsens Technologyes
  80. 7.14.1 Xsens Technologyes Company Information
  81. 7.14.2 Xsens Technologyes Business Overview
  82. 7.14.3 Xsens Technologyes EMOCAP Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Xsens Technologyes EMOCAP Product Portfolio
  84. 7.14.5 Xsens Technologyes Recent Developments
  85. 7.15 Optitrack
  86. 7.15.1 Optitrack Company Information
  87. 7.15.2 Optitrack Business Overview
  88. 7.15.3 Optitrack EMOCAP Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Optitrack EMOCAP Product Portfolio
  90. 7.15.5 Optitrack Recent Developments
  91. 7.16 Codamotion
  92. 7.16.1 Codamotion Company Information
  93. 7.16.2 Codamotion Business Overview
  94. 7.16.3 Codamotion EMOCAP Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Codamotion EMOCAP Product Portfolio
  96. 7.16.5 Codamotion Recent Developments
  97. 7.17 PTI Phoenix Technologies
  98. 7.17.1 PTI Phoenix Technologies Company Information
  99. 7.17.2 PTI Phoenix Technologies Business Overview
  100. 7.17.3 PTI Phoenix Technologies EMOCAP Revenue and Gross Margin (2021-2026)
  101. 7.17.4 PTI Phoenix Technologies EMOCAP Product Portfolio
  102. 7.17.5 PTI Phoenix Technologies Recent Developments
  103. 7.18 Noraxon USA
  104. 7.18.1 Noraxon USA Company Information
  105. 7.18.2 Noraxon USA Business Overview
  106. 7.18.3 Noraxon USA EMOCAP Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Noraxon USA EMOCAP Product Portfolio
  108. 7.18.5 Noraxon USA Recent Developments
  109. 7.19 NTT Data
  110. 7.19.1 NTT Data Company Information
  111. 7.19.2 NTT Data Business Overview
  112. 7.19.3 NTT Data EMOCAP Revenue and Gross Margin (2021-2026)
  113. 7.19.4 NTT Data EMOCAP Product Portfolio
  114. 7.19.5 NTT Data Recent Developments
8 North America
  1. 8.1 North America EMOCAP Revenue (2021-2032)
  2. 8.2 North America EMOCAP Revenue by Type (2021-2032)
  3. 8.2.1 North America EMOCAP Revenue by Type (2021-2026)
  4. 8.2.2 North America EMOCAP Revenue by Type (2027-2032)
  5. 8.3 North America EMOCAP Revenue Share by Type (2021-2032)
  6. 8.4 North America EMOCAP Revenue by Application (2021-2032)
  7. 8.4.1 North America EMOCAP Revenue by Application (2021-2026)
  8. 8.4.2 North America EMOCAP Revenue by Application (2027-2032)
  9. 8.5 North America EMOCAP Revenue Share by Application (2021-2032)
  10. 8.6 North America EMOCAP Revenue by Country
  11. 8.6.1 North America EMOCAP Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America EMOCAP Revenue by Country (2021-2026)
  13. 8.6.3 North America EMOCAP Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe EMOCAP Revenue (2021-2032)
  2. 9.2 Europe EMOCAP Revenue by Type (2021-2032)
  3. 9.2.1 Europe EMOCAP Revenue by Type (2021-2026)
  4. 9.2.2 Europe EMOCAP Revenue by Type (2027-2032)
  5. 9.3 Europe EMOCAP Revenue Share by Type (2021-2032)
  6. 9.4 Europe EMOCAP Revenue by Application (2021-2032)
  7. 9.4.1 Europe EMOCAP Revenue by Application (2021-2026)
  8. 9.4.2 Europe EMOCAP Revenue by Application (2027-2032)
  9. 9.5 Europe EMOCAP Revenue Share by Application (2021-2032)
  10. 9.6 Europe EMOCAP Revenue by Country
  11. 9.6.1 Europe EMOCAP Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe EMOCAP Revenue by Country (2021-2026)
  13. 9.6.3 Europe EMOCAP Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China EMOCAP Revenue (2021-2032)
  2. 10.2 China EMOCAP Revenue by Type (2021-2032)
  3. 10.2.1 China EMOCAP Revenue by Type (2021-2026)
  4. 10.2.2 China EMOCAP Revenue by Type (2027-2032)
  5. 10.3 China EMOCAP Revenue Share by Type (2021-2032)
  6. 10.4 China EMOCAP Revenue by Application (2021-2032)
  7. 10.4.1 China EMOCAP Revenue by Application (2021-2026)
  8. 10.4.2 China EMOCAP Revenue by Application (2027-2032)
  9. 10.5 China EMOCAP Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia EMOCAP Revenue (2021-2032)
  2. 11.2 Asia EMOCAP Revenue by Type (2021-2032)
  3. 11.2.1 Asia EMOCAP Revenue by Type (2021-2026)
  4. 11.2.2 Asia EMOCAP Revenue by Type (2027-2032)
  5. 11.3 Asia EMOCAP Revenue Share by Type (2021-2032)
  6. 11.4 Asia EMOCAP Revenue by Application (2021-2032)
  7. 11.4.1 Asia EMOCAP Revenue by Application (2021-2026)
  8. 11.4.2 Asia EMOCAP Revenue by Application (2027-2032)
  9. 11.5 Asia EMOCAP Revenue Share by Application (2021-2032)
  10. 11.6 Asia EMOCAP Revenue by Country
  11. 11.6.1 Asia EMOCAP Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia EMOCAP Revenue by Country (2021-2026)
  13. 11.6.3 Asia EMOCAP Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA EMOCAP Revenue (2021-2032)
  2. 12.2 SAMEA EMOCAP Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA EMOCAP Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA EMOCAP Revenue by Type (2027-2032)
  5. 12.3 SAMEA EMOCAP Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA EMOCAP Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA EMOCAP Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA EMOCAP Revenue by Application (2027-2032)
  9. 12.5 SAMEA EMOCAP Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA EMOCAP Revenue by Country
  11. 12.6.1 SAMEA EMOCAP Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA EMOCAP Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA EMOCAP Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst